BSE filing, NSE: GODAVARI. Summary written from the filing by ALFA Finder's alert engine.
Godavari Drugs Ltd: key numbers
- Share price
- ₹119.90
- Market cap
- ₹121.4 Cr
- Revenue (annual)
- ₹105.8 Cr
- Net profit (annual)
- ₹4.09 Cr
- P/E (TTM)
- 29.2×Sector 42.0×
- Promoter holding
- 44.54%+4.31% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Godavari Drugs Ltd
All →Godavari Drugs Convertible Warrants
Godavari Drugs allotted 7,86,690 equity shares to promoter-category allottees on conversion of warrants. The balance consideration of Rs 5.25 Crore was received at an issue price of Rs 89.
- Value
- ₹5.25 Cr
Godavari Drugs Other Announcement
Godavari Drugs filed its quarterly shareholding pattern for the period ended 30 September 2026. The filing is a routine Regulation 31 disclosure with no transaction.
Godavari Drugs Other Announcement
Godavari Drugs Limited changed its Corporate Identification Number (CIN) following an alteration to its Memorandum of Association's Object Clause. The Ministry of Corporate Affairs registered the change on October 16, 2026.
Godavari Drugs Debt & Borrowing: ₹34 Cr
Godavari Drugs Limited's board approved availing working capital limits of Rs. 34 Crore from ICICI Bank. The facility is within existing shareholder-approved borrowing limits.
- Value
- ₹34.00 Cr
Godavari Drugs Annual General Meeting
Godavari Drugs held its 38th Annual General Meeting on September 25, 2026, via video conferencing. Shareholders approved financial statements, director re-appointment, and object clause alteration.
Godavari Drugs Annual General Meeting
Godavari Drugs Limited will close its register of members and share transfer books from September 19 to September 25, 2026, for its 38th Annual General Meeting.
Other board meeting date announcements
All →KS Smart Technologies Board Meeting Date
KS Smart Technologies will hold a board meeting on 13 November 2026 to approve unaudited results. The trading window stays closed until results are disseminated.
BharatRohan Airborne Innovations Board Meeting Date
BharatRohan Airborne Innovations gave notice of a board meeting on November 13, 2026, to consider unaudited standalone and consolidated results for the half year ended September 30, 2026. The meeting has not yet been held and no results are attached.
Dolphin Medical Services Board Meeting Date
Dolphin Medical Services has notified BSE of a board meeting on 14 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. The trading window stays closed until 48 hours after results publication.
Jungle Camps India Board Meeting Date
Jungle Camps India schedules a board meeting on November 13, 2026 to approve September 2026 quarter and half-year results. Trading window stays closed until November 15.
Zetwerk Manufacturing Businesses Board Meeting Date
Zetwerk Manufacturing will hold a board meeting on 13 November 2026 to consider September quarter results. Trading window stays closed until 48 hours after results are public.
Lovable Lingerie Board Meeting Date
Lovable Lingerie will hold a board meeting on 14 November 2026 to consider unaudited quarterly results for September 2026. Trading window is closed from 1 October 2026 until 16 November 2026.